AndrewLPecoraMD

PubMed

• 5 citations
  The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.
  Shaked Lev-Ari, Michael Serzan, Tianmin Wu, Andrew Ip, Lauren Pascual
  Cancer. 2023-06-15
• 7 citations
  Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.
  Maher Albitar, Hong Zhang, Ahmad Charifa, Andrew Ip, Wanlong Ma
  Heliyon. 2023-05-01
• 161 citations
  Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
  Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, Ahmad A Tarhini, Gary I Cohen
  Journal of Clinical Oncology. 2023-01-10

Journal Articles

• A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning regimen for Salvage Autologous Peripheral Blood Stem Cel...  
  Biran N, Rowley SD, Vesole DH, Zhang S, Donato ML, Richter J, Skarbnik AP, Pecora A, Siegel DS, Biol Blood Marrow Transplant, 1/1/2016
• Impact of Immune Reconstitution (IR) and Graft-Versus-Host Disease (GvHD) on Clinical Outcomes after Treatment with Donor T Cells Transduced to Express the Herpes Simp...  
  Fabio Ciceri, MD, Chiara Bonini, MD, Arnon Nagler, MD, Evangelia Yannaki, MD, Maria Teresa Lupo Stanghellini, MD, Attilio Bondanza, MD, PhD, Raffaella Greco, MD, Eduar..., Blood, 1/1/2016
• Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma (MCL)  
  Andre Goy, MD, Tommy Wu, Eric Hansen, Srikesh Arunajadai, Ewelina Protomastro, Marisa Valentinetti, BSN, RN, Maureen Murphy, BSN, RN, Judith E Smith, BSN, RN, Ruth Pe ..., Blood, 1/1/2016
• Long-Term Survival Is Demonstrated in Patients with Multiple Myeloma Treated with Allogeneic Hematopoietic Stem Cell Transplantation in Both the Consolidation and Salv...  
  Phyllis McKiernan, David S. Siegel, David H. Vesole, Tracy Andrews, Scott D. Rowley, Noa Biran, Joshua R. Richter, Andrew L. Pecora, Alan P Skarbnik, Andre Goy and Mic..., Blood, 1/1/2016
• Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies  
  Baker M, Wang H, Rowley SD, Cai L, Pecora AL, Skarbnik A, Vesole DH, Adler-Brecher B, Kim D, Donato ML, Biol Blood Marrow Transplant, 1/1/2016
• Barriers to physician adherence with evidence-based monitoring guidelines in chronic myelogenous leukemia  
  Goldberg S, Akard L, Dugan M, Federl S, Pecora A, J Oncol Practice, 1/1/2015
• Characterization of Early Stage Breast Cancer Patient Management in a Practice Setting with 21-gene Breast Cancer Assay  
  Pecora A, Waintraub S, Choi K, Rothney M, Value in Health, 1/1/2015
• The graft-versus-myeloma effect: chronic graft versus host disease prolongs survival in patients with multiple myeloma receiving allogeneic transplantation  
  Donato ML, Siegel DS, Vesole DH, McKiernan P, Nyirenda T, Pecora Al, Baker M, Goldberg SL, Mato A, Goy A, Rowley SD, Biol Blood Marrow Transplant, 1/1/2014
• Addition of Lenolidomide to rituximab, ifosphamide, carboplatin, etoposide (RICER) in first relapse/primary refractory diffuse large B cell lymphoma  
  Feldman T Mato AR, Chow KF, Protomastro EA, Yannotti KM, Bhattacharyya P, Yang X, Donato ML, Rowley S, Carini C, Valentinetti M, Smioth J, Gadaleta G, Bejot C, Stives ..., Br J Haematol, 1/1/2014
• Post-treatment PET scan is highly predictive of outcome (PFS and OS) in MCL pts treated with R-Hyper-CVAD in the frontline setting regardless of MIPI score  
  Anthony R. Mato, Ewelina Protomastro, Tania Zielonka, Tatyana Feldman, Harry Agress, Mary Timberg, Gabriella Gadaleta, Pritish Bhattacharyya, Alexandria Campaiola, Jak..., J Clin Oncol, 1/1/2014
• Efficacy of HSV-TK+ suicide gene donor lymphocytes after haploidentical transplantation (haplo-HSCT): Preliminary results of randomized TK008 study  
  Fabio Ciceri, Chiara Bonini, Arnon Nagler, Evangelia Yannaki, Maria Teresa Lupo Stanghellini, Attilio Bondanza, Giacomo Oliveira, Raffaella Greco, Eduardo Olavarria, E..., J Clin Oncol, 1/1/2014
• Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and pappilary serous ovarian cancer subtypes  
  Tamir A, Jag U, Sarojini S, Schindewolf C, Tanaka T, Gharbaran R, Patel H, Sood A, Hu W, Blake P, Chirina P, Jeong J, Lim H, Goy A, Pecora A, Shuh, Journal of Ovarian Research, 1/1/2014
• Phase II clinical trial of rapamycin-resistant donor CD4+ Th2/TH1 (T-Rapa) cells after low intensity allogeneic hematopoietic cell transplantation  
  Fowler, DH; Mossoba, ME; Steinberg, SM; Halverson, DC; Stroncek, D.; Khuu, HM; Haikim, FT; Castiello, L; Sabatino, M; Leitman, SF; Mariotti, J; Gea-Banacloche, JC; Spo..., Blood, 1/1/2013
• The role of the ubiquitin proteasome system in lymphoma  
  Suh, KS; Tanaka, T; Sarojini ,S; Nightingale, G; Gharbaran, R; Pecora, A; Goy, A, Oncol Hematol, 1/1/2013
• Focusing on clinical and economic outcomes � not guidelines  
  Pecora, A, Am J Managed Care, 1/1/2013
• Fibroblast growth factor-2(FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients  
  Gharbaran, R; Goy, A; Tanaka, T; Park, J; Kim, C; Hasan, N; Vemulapalli, S; Sarojini, S; Tuluc, M; Nalley, K; Bhattacharyya, P; Pecora, A; Suh, S, J Hematol Oncol, 1/1/2013
• Assessment of Myocardial Contractile Circumfrential strain following intracoronary stem cell infusion after myocardial infarction: MRI feature tracking feasibility study  
  Bhatti S, Al-Khalidi S, Hor H, Hakeem K, Taylor A, Quyyumi A, Oshinski A, Pecora Al, Keriakis D, Chung E, Pedrizzetti E, Miszakski G, Mazur T, ISRN Radiol, 1/1/2013
• Post-Treatment (not interim) PET-CT Scan Status Is Highly Predictive of Outcome In Mantle Cell Lymphoma Patients Treated with R-HyperCVAD  
  Mato A, Goy A, Pecora AL, et al, Cancer, 1/1/2012
• Intracoronary Bone Marrow Mononuclear Cells after Myocardial Infarction  
  A. Quyyumi MD, Andrew L. Pecora MD, JAMA, 1/1/2012
• Three dimensional cell culture models for biomarker discoveries and Cancer Research  
  Caicedo-Carvajal CE, Liu Q, Goy A, Pecora A, Suh KS, Translational Medicine, 1/1/2012
• Early detection biomarkers for ovarian cancer  
  Sarojini, S; Tamir, A; Lim, H; Li, S; Zhang, S; Goy, A; Pecora, A; Suh, KS, J. Oncology, 1/1/2012
• A phase III study of B4-blocked ricin as adjuvant therapy post-autologus bone marrow transplant: CALGB 9254  
  Furman RR, Grossbard ML, Johnson JL, Pecora AL, Cassileth PA, Jung SH, Peterson BA, Nadler LM, Freedman A, Bayer RL, Barlett NL, Hurd DD, Cheson BD, Leuk Lymphoma, 1/1/2011
• CD34+ cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent  
  Quyyumi A, Waller E, Murrow J, Esteves F, Galt J, Oshinski J, Lerakis S, Sher S, Vaughan D, Perin E, Willerson J, Kereiakes D, Gersh B, Gregory D, Werner A, Moss T, Ch..., American Heart Journal, 1/1/2011
• Incidence and clinical complications of myelodysplastic syndrome among United States Medicare beneficiaries  
  Goldberg S, Chen Er, Corral M, Mody-Patel N, Pecora AL, Laouri M, J Clin Oncol, 1/1/2010
• Phase 1 study of recombinant interleukin 7 administration in subjects with refractory malignancy  
  Sportes C, Babb R, Krumlauf M, Hakim F, Steinberg S, Chow C, Brown M, Fliesher T, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet M, Moree M, Amato R, Pecora AL,..., Clin Cancer Res, 1/1/2010
• Join now to see all

Books/Book Chapters

• Gene Therapy for Cancer 
  Chapter: Phase I Clinical Experience with Intravenous Administration of PV 701 an Oncolytic Virus. Gene Therapy for Cancer. 
  Page 399.0 - 409.0Pecora AL and Lorence RMHumana Inc2007
• Autologous Blood and Marrow Transplant X: Proceedings of the Tenth International Symposium 
  Chapter: Lymphoma 
  Shenkheim D, Pecora AL Elfenbien G et alEditors: Dicke and Keating.2001
• Handbook of Bone Marrow Transplantation 
  Chapter: CD34+ Cell Selection and Ex Vivo Expansion In Autologous and Allogeneic Transplantation 
  Page 1.0 - 20.0Pecora ALMartin Dunitz Ltd2000
• Hematopoietic Stem Cell Transplantation 
  Chapter: CD34 Selection Using Immunomagnetic Beads 
  Page 223.0 - 229.0Preti RA, Pecora AL, Ahmed T, Farley JMarcel Dekker, Inc2000
• Stem Cell Quantification 
  Chapter: Stem Cell Quantification: The ISHAGE Guidelines For CD34+ Determination-Applications in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation 
  Page 298.0 - 311.0Sutherland DR, Keeney M, Pecora A, Chin-YeeChurchill Ltd2000
• Join now to see all

Abstracts/Posters

• Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 Patients
  Andrew L. Pecora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Sustained Hematopoietic Recovery after Salvage Autologous Stem Cell Transplants after Long Term Storage of Cryopreserved Hematopoietic Progenitor Stem Cells (HPSC)
  Andrew L. Pecora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Evomela¬ Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation
  Andrew L. Pecora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Predictive value of the patient reported outcome �living with cancer� instrument on overall survival in advanced cancer patients: A tool for guiding timing of palliati...
  Goldberg SL, Paramanathan D, Arunajadai S, DeVincenzo V, Pe Benito R, Gruman B, Kaur S, Goy A, Niranjan U, Fitzgerald D, Childs JW, Lee JW, Abdo-Matkiwsky MD, Choi K, ..., J Clin Oncol, 1/1/2017
• Are Cancer Patients Concerned About Burdening Their Families?
  Pecora A, ASCO Palliative Care Symposium, 1/1/2016
• Validation of the Living With Cancer (LWC) PRO Tool for Identifying Cancer Patients (pts) Appropriate for End of Life Care Consultations
  Pecora A, ASCO Palliative Care Symposium, 1/1/2016
• Genomic Profiling of non-small cell lung cancer in the community setting
  Gutierrez M, Choi K, Lanman RB, Skrzypczak SM, et al, J Clin Oncol, 1/1/2016
• Growth factor use and costs in breast cancer patients undergoing adjuvant therapy
  Hyun gi Noh, Dhakshila Paramanathan, Kiran Suryadevara, Kelly Choi, Augie Smith, William Kea, Eric V Schultz, Andrew Pecora, Stuart L. Goldberg, J Clin Oncol, 1/1/2016
• Are patients with advanced cancer concerned about financial toxicity?
  Paramanathan D, Kaur S, Daswani S, et al, J Clin Oncol, 1/1/2016
• Early economic benefits of gene expression profiling using a 21-gene panel among patients with early stage, lymph node negative, hormone receptor positive, her2-neu on...
  Waintraub SE, McNamara DM, Graham DA, et al, J Clin Oncol, 1/1/2016
• Inhibition of HIF Prolyl Hydroxylases Mitigate Gut Graft-Versus-Host Disease
  Rena Feinman, PhD, Iriana Colorado, MSc, Keyi Wang, MSc, Eugenia Dziopa, MSc, Michael A Flynn, MSc, Kevin Peters, MD, Andrew L. Pecora, MD and Robert Korngold, PhD, 1/1/2016
• 5-Day Decitabine with Mini Fludarabine and Busulfan Yields Comparable Outcomes to Mini Flu/Bu but with Increased Incidence of Severe Acute GvHD
  Melissa Baker, APN, Tracy Andrews, MA, Scott D. Rowley, MD, Andrew L. Pecora, MD, Alan P Skarbnik, MD, David H. Vesole, MD, PhD, Andre Goy, MD, Maria Cortes, APN, Ange..., 1/1/2016
• Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma (MCL)
  Andre Goy, MD, Tommy Wu, Eric Hansen, Srikesh Arunajadai, Ewelina Protomastro, MS, Marisa Valentinetti, BSN, RN, Maureen Murphy, BSN, RN, Judith E Smith, BSN, RN, Ruth..., Blood, 1/1/2016
• Day Decitabine with Mini Fludarabine and Busulfan Yields Comparable Outcomes to Mini Flu/Bu but with Increased Incidence of Severe Acute GvHD
  Melissa Baker, APN, Tracy Andrews, MA, Scott D. Rowley, MD, Andrew L. Pecora, MD, Alan P Skarbnik, MD, David H. Vesole, MD, PhD, Andre Goy, MD, Maria Cortes, APN, Ange..., Blood, 1/1/2016
• Impact of Immune Reconstitution (IR) and Graft-Versus-Host Disease (GvHD) on Clinical Outcomes after Treatment with Donor T Cells Transduced to Express the Herpes Simp...
  Fabio Ciceri, MD, Chiara Bonini, MD, Arnon Nagler, MD, Evangelia Yannaki, MD, Maria Teresa Lupo Stanghellini, MD, Attilio Bondanza, MD, PhD, Raffaella Greco, MD, Eduar..., Blood, 1/1/2016
• Characterization of Early Stage Breast Cancer Patient Management in a Practice Setting with the 21-Gene Breast Cancer Assay
  Pecora A, Waintraub S, Choi K, et al, Value in Medicine, 1/1/2015
• Utilization and clinical impact of genomic profiling for EGFR and ALK in non-squamous non-small cell lung cancer (NSCLC) in the community setting
  Gutierrez M, Harper HD, Halibey BE, Miller VA, Conway J, Oldroyd M, Choi K, Schultz EV, Pecora A, Goldberg SL, J Clin Oncol, 1/1/2015
• Prevalence of clinically meaningful prognostic variability in cancer: An analysis using a new taxonomy system
  Pecora A, Schultz EV, Choi K, Smith A, LaRock B, Paramanathan D, DeRosa WT, Goy A, Licitra EJ, Siegel DS, Goldberg SL, J Clin Oncol, 1/1/2015
• Novel Chromatin Modifying Gene Alterations and Significant Survival Association of ATM and P53 in Mantle Cell Lymphoma
  Kai Wang, MD, PhD, Michelle K. Nahas, PhD, Roman Yelensky, PhD, Geoff A. Otto, PhD, Doron Lipson, PhD, Jie He, PhD, Jeff Ross, MD, Phil J Stephens, PhD, Kar Fai Chow, ..., American Society of Hematology, 1/1/2014
• Haploidentical Allogeneic Transplantation Provides Comparable Outcomes to HLA-Matched or Mismatched Unrelated Donor Grafts in Hematological Malignancies
  Melissa F Baker, APN, Daniel Kim, Michele L Donato, MD, FACP, Andrew L Pecora, MD, FACP, David H. Vesole, MD, PhD, Alan P Skarbnik, MD, Barbara Adler-Brecher, Michele ..., American Society of Hematology, 1/1/2014
• Vascular Disease: Biology and Clinical Science Session Title: Novel Therapies and Treatment Strategies for Patients with Acute Coronary Syndromes
  A. Quyyumi, A. Vasquez,M. Klapholz D.J. Kereiakes, G.L. Schaer, K. Fujise, A. Abdel-Latif: R.S. Iwaoka, A.E. Denktas, R. Gammon, S.C. Frohwein, V. Kasi, M.R. Tamberell..., American Heart Association, 1/1/2014
• Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020
  Howard Kaufman, Jose Lutzky, Joseph Clark, Kim Allyson Margolin, David H. Lawson, Asim Amin, Frances A. Collichio, Andrew Pecora, Walter John Urba, Kelly L. Bennett, D..., J Clin Oncol, 1/1/2013
• Decitabine Plus Mini Fludarabine and Busulfan Yields Durable Engraftment with Low Relapse Rates in Elderly or Medically Infirm Patients with Myeloid Malignancies
  Baker Melissa F; Rowley Scott D.; Goldberg, Stuart L.; Mato Anthony R.; Pecora Andrew L.; Vesole, David H.; McKiernan Phyllis; Goy Andre; Donato Michele L., American Society of Hematology, 1/1/2012
• A Phase I/II Study of Escalating Doses of Thalidomide (Thal) in Conjunction with Brotezomib (Vel) and High Dose Melphalan (Mel) As A Conditioning Regimen for Autologou...
  Hong Sung H.; Siegel David S.; Donato Michele L.; Vesole David H.; Pecora Andrew L.; Richter Joshua R.; Brown Emily; Buttner Kathryn; DelFavero Marie; Kim Daniel; Orte..., American Society of Hematology, 1/1/2012
• Ricer (Rituximab, Ifosfamide, Carboplatin, Etoposide, Revlimid) Is Well-Tolerated Salvage Regimen in First Relapse/Primary Refractory DLBCL Allowing Consolidation with...
  Mato Anthony R.; Donato Michele L.; Rowley Scott D.; Goldberg Stuart L; Carini Carolanne; Valentinetti Marisa; Smith Judith; Gadaleta Gabriella; Bejot Coleen; Stives S..., American Society of Hematology, 1/1/2012
• Join now to see all

Lectures

• Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplan... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Infusion of Donor Lymphocytes Genetically Engineered to Express the Herpes Simplex Virus Thymidine Kinase (HSV-TK) Suicide Gene after Haploidentical Hematopoietic Stem... 
  1/1/2014
• Pre-Emptive T-Rapa Cell DLI for Therapy of High Risk Lymphoma after Low-Intensity Allogeneic HCT 
  1/1/2012
• CD34+CXCR4+ cell therapy (AMR-001) for myocardial infarction: Preliminary processing and product results of a phase I Dose escalation study 
  1/1/2007
• Protect your Genes 
  Ridgewood, NJ - 1/1/2004
• An Intravenous Phase I Trial of a Replication-competent Virus, PV701 in the Treatment of Advanced Cancers 
  1/1/2001
• Myelodysplastic Syndrome (MDS) and Leukemia After Autotransplant for Lymphoma: A Mulicenter Case Control Study 
  1/1/2001
• Cell Processing; Experimental Stem Cell Mobilization II 
  1/1/2000
• What to Do When You Can�t Collect Enough Cells for Transplant 
  Ravenna, Italy - 1/1/1999
• The Effect of Induction Chemotherapy Prior to Sequential High Dose Chemotherapy 
  1/1/1999
• What to Do For the Poor Mobilizing Patient 
  Ravenna, Italy - 1/1/1999
• Clinical Application of Stem Cell Expansion 
  San Francisco, CA - 1/1/1999
• Future Trends In Stem Cell Therapies 
  Washington, DC - 1/1/1999
• Colloquium on Bone Marrow Transplant and Breast Cancer Trials 
  1/1/1999
• Breast Cancer Cell Contamination of Blood Stem Cell Products In Patients with Metastatic Breast Cancer: Predictors and Clinical Outcomes 
  1/1/1999
• Blood Stem Cell (BSC) Transplantation In Metastatic Breast Cancer Using CD34 Positive Selection With or Without Negative Selection for Tumor Cells Using the ISOLEX 300... 
  1/1/1998
• Changing Concepts In Breast Cancer 
  University of Pennsylvania Cancer Center - 1/1/1998
• High-Dose Chemotherapy - Emerging Trends in Stem Cell Therapy 
  Phoenix, Arizona - 1/1/1998
• CD34 Subsets and Engraftment 
  1/1/1998
• Models for Facilitating Clinical Trials 
  1/1/1998
• Stem Cell Support of High Dose Chemotherapy: Emerging Trends to Hematopoietic Recovery 
  1/1/1997
• Advances in the Treatment of Breast Cancer 
  1/1/1997
• Clinical Relevance and Application of Tumor Cell Depletion Using CD34+ Cell Selection or Ex-vivo Expansion 
  1/1/1997
• Contamination in Peripheral Blood Stem Cell (PBSC) Collections Association with Bone Marrow Disease and Type of Mobilization 
  Robert Woods Johnson Medical School - 1/1/1997
• Join now to see all